e-Profile Login and ID Quick Search
South Carolina Requires Electronic Tracking of PSE-Product Sales
All pharmacies and retailers in the state of South Carolina that sell over-the-counter cold and allergy medications containing ephedrine, pseudoephedrine, and/or phenylpropanolamine products (PSE) are required to participate in a statewide, real-time electronic PSE monitoring program for the purpose of tracking illegal PSE purchases. In compliance with 2010 South Carolina Code of Laws Act 242, South Carolina Law Enforcement Division (SLED) joined the National Precursor Log Exchange (NPLEx) to develop the program. The technology provider, Appriss, will provide a Web-accessed database at no charge to South Carolina pharmacies and retailers.
Pursuant to the Combat Methamphetamine Epidemic Act (CMEA) of 2005, pharmacies and retailers are currently required to capture certain data regarding PSE sales. The NPLEx system enables pharmacies to easily enter the same PSE sales data currently being gathered online, rather than recording the information into a manual log or in-store computer system. NPLEx will provide the pharmacy with a “Do Not Sell” recommendation at the time of the sale if a customer has exceeded state and/or federal PSE limits. Customers can be directed to a public Web site that will allow them to get more information as to why they were unable to purchase the PSE product. Data will be stored in a secure, central repository that treats the data collected as if it were Health Insurance Portability and Accountability Act data. Furthermore, the collected data will be viewable by law enforcement, in order to comply with CMEA and 2010 South Carolina Code of Laws Act 242. More information is available in the February 2011 South Carolina Board of Pharmacy Newsletter (PDF).
